Abstract
Between January 1980 and March 1993, 166 patients with renal cell carcinoma were treated at Nagoya University Hospital. Among them 16 (9.6%) underwent surgical removal of 21 metastatic lesions: 12 patients had distant metastases at diagnosis and the other 4 demonstrated new distant metastases during their clinical course after nephrectomy. The metastatic lesions involved the brain in 6 patients, bone in 4, lung in 2, contralateral adrenal glands in 2, soft tissues in 2, lymph nodes in 2, pleura in 1, pancreas in 1, and contralateral renal pelvis in 1. All of the 16 patients underwent nephrectomy and 15 of them (93%) received interferon-α therapy. Patients with lesions which were completely resected had significantly longer survival than those with lesions which were palliatively treated and those with metastatic lesions at other sites (p=0.02). Improvement of performance status was observed in 5 of 6 (83%) patients undergoing palliative surgical treatment. The present study suggests that surgical removal of metastatic lesions prolongs survival in a limited number of renal cell carcinoma patients and that it improves performance status in those symptoms related to metastasis.
Similar content being viewed by others
References
Skinner, D. G., Colvin, R. B., Vermillion, C. D., Pfister, R. C., Leadbetter, W. F.: Diagnosis and management of renal cell carcinoma: A clinical and pathologic study of 309 cases.Cancer, 28, 1165 (1971).
Takashi, M., Nakano, Y., Sakata, T., Miyake, K., Hamajima, N.: Multivariate evaluation of prognostic determinants for renal cell carcinoma.Urol. Int., 50, 6 (1993).
Montie, J. E., Stewart, B. H., Straffon, R. A., Banowsky, L. H. W., Hewitt, C. B., Montague, D. K.: The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma.J. Urol., 117, 272 (1977).
Quesada, J. R.: Role of interferons in the therapy of metastatic renal cell carcinoma.Urology, 34 (Suppl.), 80 (1989).
Middleton, R. G.: Surgery for metastatic renal cell carcinoma.J. Urol., 97, 973 (1967).
Tolia, B. M., Whitmore, W. F. Jr.: Solitary metastasis from renal cell carcinoma.J. Urol., 114, 836 (1975).
deKernion, J. B., Ramming, K. P., Smith, R. B.: The natural history of metastatic renal cell carcinoma: A computer analysis.J. Urol., 120, 148 (1978).
O'dea, M. J., Zincke, H., Utz, D. C., Bernatz, P. E.: The treatment of renal cell carcinoma with solitary metastasis.J. Urol., 120, 540 (1978).
Golimbu, M., Al-Askari, S., Tessler, A., Morales, P.: Aggressive treatment of metastatic renal cancer.J. Urol., 136, 805 (1986).
Hermanek, P., Sobin, L. H.: TNM Classification of Malignant Tumours. 4th ed. Springer-Verlag, Berlin 1987.
Skeel, R. T.: Systematic assessment of the patient with cancer. In: Skeel, R. T. (ed.). Handbook of Cancer Chemotherapy. 2nd ed. Little Brown, Boston 1987, pp. 15–24.
Kaplan, E. L., Meier, P.: Nonparametric estimation from incomplete observations.J. Am. Stat. Assoc., 53, 457 (1958).
Gehan, E. A.: A generalized Wilcoxon test for comparing arbitrarily single-censored samples.Biometrika, 52, 203 (1965).
Takashi, M., Sakata, T., Sai, Y., Shimoji, T., Miyake, K.: Metastasis of renal cell carcinoma to the contralateral renal pelvis.Urol. Int., 51, 102 (1993).
Selli, C., Hinshaw, W. M., Woodard, B. H., Paulson, D. F.: Stratification of risk factors in renal cell carcinoma.Cancer, 52, 899 (1983).
Siminovitch, J. M. P., Montie, J. E., Straffon, R. A.: Prognostic indicators in renal cell adenocarcinoma.J. Urol., 130, 20 (1983).
Takashi, M., Sakata, T., Nakano, Y., Nagai, T., Takaba, H., Tanaka, J., Okamura, K., Takamura, S., Kanai, S., Sahashi, M., Murase, T., Shimoji, T., Miyake, K.: Clinical characteristics and prognosis of renal cell carcinoma: Statistical evaluation of possible determinants for distant metastasis, venous tumor thrombi, and lymph node metastasis.Jpn. J. Urol., 83, 321 (1992).
Neves, R. J., Zincke, H., Taylor, W. F.: Metastatic renal cell cancer and radical nephrectomy: Identification of prognostic factors and patient survival.J. Urol., 139, 1173 (1988).
Krown, S. E.: Interferon treatment of renal cell carcinoma: Current status and future prospects.Cancer, 59, 647 (1987).
Dreicer, R., Williams, R. D.: Renal parenchymal neoplasms. In: Tanagho, E. A., McAninch, J. W. (eds): Smith's General Urology. 13th ed. Appleton & Lange, Norwalk 1992, pp. 359–377.
Sella, A., Swanson, D. A., Ro, J. A., Putnam, J. B., Jr., Amato, R. J., Markowitz, A. B., Logothetis, C. J.: Surgery following response to interferon-α-based therapy for residual renal cell carcinoma.J. Urol., 149, 19 (1993).
Tanioka, F., Hiroi, M., Moriki, T., Yamashita, M., Yamane, T., Hara, H., Iijima, S.: Proliferating cell nuclear antigen (PCNA). Immunostaining in renal cell carcinoma and its relationship to tumor grading, flow cytometric DNA analysis and prognosis.GBK Fortbild. aktuel. Krebsdiagn. Therap., 62, 17 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takashi, M., Takagi, Y., Sakata, T. et al. Surgical treatment of renal cell carcinoma metastases: Prognostic significance. International Urology and Nephrology 27, 1–8 (1995). https://doi.org/10.1007/BF02575213
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02575213